Joni Kamiya is an occupational therapist by training and an ag-vocate in Hawaii on the biotechnology issue.
"Can you imagine?" Life-extending technology is a serious enough prospect to have merited its own chapter in "Beyond Therapy," a report on biotechnology issued last fall by the President's Council on Bioethics.
The Market Came to Them An 80percentt stake in technology stocks, with a sprinkling of biotechnology issues, pushed the $1.22 billion Kopp Emerging Growth fund into the No. 3 place for the quarter, with a return of 42.3percentt.
The union, an independent organization that has opposed the Bush administration on environmental policies and the Clinton administration on biotechnology, issued a report last Wednesday accusing the administration of distorting science to serve its political goals.
According to Dr. Henry Miller, who had a leading role in biotechnology issues at the FDA from 1979 to 1994, "In this area, the U.S. government agencies have done exactly what big agribusiness has asked them to do and told them to do".
In December, Jon Entine, the executive director of the Genetic Literacy Project, a nonpartisan nonprofit group that promotes education about biotechnology issues, wrote an article in Slate suggesting that the holdup wasn't with the F.D.A., which had completed the report, but with the Obama administration, which had just finished a re-election campaign.
While a senator and self-styled expert on biotechnology issues, Gore praised Algeny, the bizarre diatribe by anti-biotechnology zealot Jeremy Rifkin and is quoted on its cover, calling it "an important book" and an "insightful critique of the changing way in which mankind views nature".
The boom in US biotechnology issues that began a year ago multiplied IBT's asset value as the imminence of the completion of the human genome project spurred on some remarkable gains.
"In this area, the U.S. government agencies have done exactly what big agribusiness has asked them to do and told them to do," said Dr. Henry Miller, a senior research fellow at the Hoover Institution, who was responsible for biotechnology issues at the Food and Drug Administration from 1979 to 1994.
Any of the 103 nuclear reactors in the United States could have an accident with consequences as great or greater than Chernobyl, observed Mr. Pollard, who worked for the Union of Concerned Scientists, a nonprofit organization in Cambridge, Mass., which focuses on arms control, energy and biotechnology issues.
Biotechnology issues, hit hard last week, were beaten down again yesterday.
